Upregulation of the transcription factor GATA-3 in upper airway mucosa after in vivo and in vitro allergen challenge

被引:50
作者
Nakamura, Y
Christodoulopoulos, P
Cameron, L
Wright, E
Lavigne, F
Toda, M
Muro, S
Ray, A
Eidelman, DH
Minshall, E
Hamid, Q
机构
[1] McGill Univ, Meakins Christie Labs, Montreal, PQ H2X 2P2, Canada
[2] McGill Univ, Jewish Gen Hosp, SMBD, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H3T 1E2, Canada
[3] Univ Montreal, Notre Dame Hosp, Montreal, PQ H3C 3J7, Canada
[4] Yale Univ, Sch Med, Dept Med, Pulm & Crit Care Sect, New Haven, CT 06510 USA
关键词
allergic rhinitis; IL-5; GATA-3; transcription factors; allergen;
D O I
10.1067/mai.2000.107045
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Allergic rhinitis is a complex upper airways disorder characterized by the infiltration of eosinophils and T-H2-type T lymphocytes. GATA-3 is a novel transcription factor recently shown to regulate IL-5 and, possibly, IL-4 gene expression. We previously reported that GATA-3 is increased within the bronchial mucosa of allergic asthmatic subjects compared with control subjects. Objective: In the present study we set out to determine whether there is also an increased number of cells expressing GATA-3 messenger (m)RNA within the nasal mucosa of patients with allergic rhinitis. Methods: Inferior turbinate biopsy specimens mere obtained from patients with allergic rhinitis and nonatopic control subjects before and after local allergen provocation in vivo. To assess the contribution of resident cells expressing GATA-3 mRNA, we also performed isolated explant studies in which nasal mucosal tissue from subjects with allergic rhinitis and nonatopic control subjects was cultured in allergen-treated medium The presence of mRNA coding for GATA-3, IL-5, IL-4, IL-13, and GM-CSF was assessed by using in situ hybridization. Results: The number of GATA-3 mRNA(+) cells was increased after local allergen provocation in vivo (increase in GATA-3 mRNA(+) cells [mean +/- SEM]: subjects,vith allergic rhinitis, 11.3 +/- 8.7; control subjects, 1.2 +/- 4.1; P < .05) and in explanted nasal mucosa in vitro (subjects with allergic rhinitis, 10.2 +/- 3.8; control subjects, 2.7 +/- 4.4; P < .05). The gene expression of GATA-3 was significantly correlated to the numbers of IL-5 (r = 0.87) and GM-CSF (r = 0.79) mRNA(+) cells but not with IL-4 or IL-13 mRNA(+) cells. Conclusion: In summary, the expression of the transcription factor GATA-3 was increased after allergen challenge, and this was evident in the absence of de novo inflammatory cell recruitment. GATA-3 may be a potential target in the treat ment of allergic diseases, such as rhinitis.
引用
收藏
页码:1146 / 1152
页数:7
相关论文
共 27 条
[1]   Regulation of the human interleukin-5 promoter by Ets transcription factors -: Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1 [J].
Blumenthal, SG ;
Aichele, G ;
Wirth, T ;
Czernilofsky, AP ;
Nordheim, A ;
Dittmer, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12910-12916
[2]   Evidence for local eosinophil differentiation within allergic nasal mucosa: Inhibition with soluble IL-5 receptor [J].
Cameron, L ;
Christodoulopoulos, P ;
Lavigne, F ;
Nakamura, Y ;
Eidelman, D ;
McEuen, A ;
Walls, A ;
Tavernier, J ;
Minshall, E ;
Moqbel, R ;
Hamid, Q .
JOURNAL OF IMMUNOLOGY, 2000, 164 (03) :1538-1545
[3]   Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: Effect of topical corticosteroids [J].
Christodoulopoulos, P ;
Wright, E ;
Frenkiel, S ;
Luster, A ;
Hamid, Q .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (06) :1036-1044
[4]  
DURHAM SR, 1992, J IMMUNOL, V148, P2390
[5]   GATA-3 significantly downregulates IFN-γ production from developing Th1 cells in addition to inducing IL4-and IL-5 levels [J].
Ferber, IA ;
Lee, HJ ;
Zonin, F ;
Heath, V ;
Mui, A ;
Arai, N ;
O'Garra, A .
CLINICAL IMMUNOLOGY, 1999, 91 (02) :134-144
[6]  
Ghaffar O, 2000, CLIN EXP ALLERGY, V30, P86
[7]   IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: Comparison with IL-4 expression and modulation by topical glucocorticoid therapy [J].
Ghaffar, O ;
Laberge, S ;
Jacobson, MR ;
Lowhagen, O ;
Rak, S ;
Durham, SR ;
Hamid, Q .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (01) :17-24
[8]   LOCALIZATION OF ATRIAL-NATRIURETIC-PEPTIDE MESSENGER-RNA AND IMMUNOREACTIVITY IN THE RAT-HEART AND HUMAN ATRIAL APPENDAGE [J].
HAMID, Q ;
WHARTON, J ;
TERENGHI, G ;
HASSALL, CJS ;
AIMI, J ;
TAYLOR, KM ;
NAKAZATO, H ;
DIXON, JE ;
BURNSTOCK, G ;
POLAK, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (19) :6760-6764
[9]   EXPRESSION OF MESSENGER-RNA FOR INTERLEUKIN-5 IN MUCOSAL BRONCHIAL BIOPSIES FROM ASTHMA [J].
HAMID, Q ;
AZZAWI, M ;
YING, S ;
MOQBEL, R ;
WARDLAW, AJ ;
CORRIGAN, CJ ;
BRADLEY, B ;
DURHAM, SR ;
COLLINS, JV ;
JEFFERY, PK ;
QUINT, DJ ;
KAY, AB .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05) :1541-1546
[10]   In vivo expression of IL-12 and IL-13 in atopic dermatitis [J].
Hamid, Q ;
Naseer, T ;
Minshall, EW ;
Song, YL ;
Boguniewicz, M ;
Leung, DYM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (01) :225-231